MedTrace Logo

Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery

NCT07723300 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-07-23

No results posted yet for this study

Summary

The goal of this clinical trial is to learn how a partially self-supervised constraint-induced movement therapy (sCIMT) program in adults with arm and hand weakness will work after stroke. This study will look at whether the program can help people improve the use of their arm and hand after a stroke while requiring less time with a therapist. The main questions it aims to answer are:

* Does the sCIMT program help people use their affected arm and hand better - after a stroke?
* Do participants feel that the sCIMT program is useful, easy to follow, and a good fit for their recovery needs?
* Does taking part in the sCIMT program improve participants' quality of life and daily well-being?

Participants will:

* Take part in a therapy program 5x/week for 2 weeks. The program is designed to help improve the use of the arm and hand affected by stroke.
* Wear a mitt on the stronger hand during certain practice activities to encourage use of the weaker hand.
* Complete surveys and tests before and after the program to measure arm and hand use, experiences with the program, and quality of life.

Conditions

  • Stroke
  • Stroke (CVA) or TIA
  • Cerebral Vascular Accident (CVA)/Stroke

Interventions

BEHAVIORAL

Self-Supervised Constraint-Induced Movement Therapy (sCIMT)

Self-supervised constraint-induced movement therapy (sCIMT) is an upper extremity rehabilitation intervention for individuals with stroke. Participants receive up to 30 hours of rehabilitation over 2 weeks (3-hour sessions, up to 5 sessions per week). The intervention combines therapist-guided training with self-supervised task practice, with approximately one-third of treatment time delivered individually by a therapist and two-thirds completed independently. Treatment activities include task-oriented functional and non-functional upper extremity exercises designed to promote use of the affected arm, improve motor function, and support functional recovery.

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07723300 on ClinicalTrials.gov